9 Meters Biopharma, Inc. Gains 31.11%

Thu, Jun 23, 2022 at 08:30 PM

9 Meters Biopharma, Inc. (NMTR:NASDAQ) shot up at $0.35, a gain of 31.1%. The stock got featured on our News Catalysts scanner on Tue, Jun 21, 2022 at 09:49 AM in the 'BIOTECH' category. From Thu, Jun 09, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days

The stock spiked on Thu, Jun 09, 2022 at $0.66 with a volume of 2M+.

About 9 Meters Biopharma, Inc. (NMTR:NASDAQ)

Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for an autoimmune/ inflammatory disease. It includes drug candidates for celiac disease, NASH, Crohn's, and ulcerative colitis.

Top 10 Gainers:

Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
Vroom Inc. (VRM:NASDAQ), 36.44%
Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
Molecular Data Inc. (MKD:NASDAQ), 32.18%
Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
22nd Century Group Inc (XXII:NASDAQ), 31.12%
9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%